Publicacións (16) Publicacións de Iria Rodríguez Osorio

filter_list

2022

  1. Programa de alternativa a la hospitalización por IC aguda. Resultados piloto

    Galicia Clínica, Vol. 83, Núm. 2, pp. 68-69

2019

  1. Effectiveness and safety of daclatasvir/sofosbuvir with or without ribavirin in genotype 3 hepatitis c virus infected patients. Results in real clinical practice

    Revista Espanola de Quimioterapia, Vol. 32, Núm. 2, pp. 137-144

  2. Liver-related events and mortality among elderly patients with advanced chronic hepatitis C treated with direct-acting antivirals

    PLoS ONE, Vol. 14, Núm. 6

  3. Teleconsultation for the Pharmaceutical Care of HIV Outpatients in Receipt of Home Antiretrovirals Delivery: Clinical, Economic, and Patient-Perceived Quality Analysis

    Telemedicine and e-Health, Vol. 25, Núm. 5, pp. 399-406

2018

  1. Darunavir/cobicistat maintains the effectiveness of darunavir/ritonavir in HIV-infected patients under mono or dual therapy

    HIV Clinical Trials, Vol. 19, Núm. 5, pp. 197-201

2017

  1. Cancer incidence in persons living with HIV

    Clinical Infectious Diseases

  2. Increased incidence of cancer observed in HIV/hepatitis C virus-coinfected patients versus HIV-monoinfected

    AIDS, Vol. 31, Núm. 8, pp. 1099-1107

  3. Liver-related mortality and hospitalizations attributable to chronic hepatitis C virus coinfection in persons living with HIV

    HIV Medicine, Vol. 18, Núm. 9, pp. 685-689

  4. Real life experience with direct-acting antivirals agents against hepatitis C infection in elderly patients

    Journal of Clinical Virology, Vol. 88, pp. 58-61

  5. Tendencia de las hospitalizaciones, reingresos y mortalidad intrahospitalaria en los pacientes infectados por VIH entre 1993-2013: impacto de la coinfección por el virus de la hepatitis C

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 35, Núm. 1, pp. 20-26

  6. Viral dynamics among hepatitis C virus chronic infected patients during direct-acting antiviral agents therapy: Impact for monitoring and optimizing treatment duration

    European Journal of Gastroenterology and Hepatology, Vol. 29, Núm. 7, pp. 781-785

2016

  1. Any impact of blips and low-level viraemia episodes among HIV-infected patients with sustained virological suppression on ART?

    Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 4, pp. 1051-1055

  2. European mitochondrial haplogroups impact on liver fibrosis progression among HCV and HIV/HCV-coinfected patients from Northwest Spain

    Journal of Acquired Immune Deficiency Syndromes, Vol. 73, Núm. 2, pp. 149-153

2015

  1. How useful is the ABCD2 TIA score in predicting and preventing stroke?

    Galicia Clínica, Vol. 76, Núm. 3, pp. 107-111

  2. Lung cancer in patients living with HIV infection

    AIDS

2014

  1. High prevalence of subtype F in newly diagnosed HIV-1 persons in northwest Spain and evidence for impaired treatment response

    AIDS, Vol. 28, Núm. 12, pp. 1837-1840